We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Niox Group plc (NIOX) ORD GBP0.0008

Sell:69.60p Buy:70.00p 0 Change: 3.40p (5.11%)
FTSE AIM 100:1.28%
Market closed |  Prices as at close on 29 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:69.60p
Buy:70.00p
Change: 3.40p (5.11%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 29 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:69.60p
Buy:70.00p
Change: 3.40p (5.11%)
Market closed |  Prices as at close on 29 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • Niox Group reports solid growth in final results

    26 March 2024 14:33

    (Sharecast News) - Niox Group reported a robust 18% increase in revenue in its final results on Tuesday, amounting to £36.8m compared to £31.3m in the prior year.

  • Niox Group flags solid revenue jump in 2023

    18 January 2024 15:08

    (Sharecast News) - Medical device company Niox Group said in a trading update on Thursday that it experienced substantial revenue growth in 2023, with a reported increase of 18% to £36.8m.

  • Niox posts growth amid business model transition

    26 September 2023 13:40

    (Sharecast News) - Asthma-focussed medical device developer Niox Group reported a robust 21% increase in first-half revenue on Tuesday, reaching £18.8m.

  • Niox Group describes very strong first-half

    18 July 2023 09:07

    (Sharecast News) - Asthma diagnosis and management device specialist Niox Group described a strong first-half in a trading update on Tuesday, with revenue growing 22% to around £18.8m.

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.

© Digital Look Ltd 1998-2024. All rights reserved.

Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.